Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder

Objective: Current extended-release (ER) formulations of psychostimulants used for treatment of attention-deficit/hyperactivity disorder (ADHD) provide an extended duration of ADHD symptom control; however, the onset of efficacy can be protracted and variable, leaving the early morning untreated. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Childress, Ann, Mehrotra, Shailly, Gobburu, Jogarao, McLean, Angus, DeSousa, Norberto J., Incledon, Bev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771548/
https://www.ncbi.nlm.nih.gov/pubmed/29039979
http://dx.doi.org/10.1089/cap.2017.0044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771548/
https://www.ncbi.nlm.nih.gov/pubmed/29039979
http://dx.doi.org/10.1089/cap.2017.0044

Ejemplares similares